These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 3090558
1. Prevention of neural myoinositol depletion in diabetic rats by aldose reductase inhibition with tolrestat. Kemper C, Dvornik D. Proc Soc Exp Biol Med; 1986 Sep; 182(4):505-10. PubMed ID: 3090558 [Abstract] [Full Text] [Related]
2. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors. Sredy J, Flam BR, Sawicki DR. Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565 [Abstract] [Full Text] [Related]
3. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats. Tomlinson DR, Sidenius P, Larsen JR. Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664 [Abstract] [Full Text] [Related]
4. Prolonged fructose feeding and aldose reductase inhibition: effect on the polyol pathway in kidneys of normal rats. Bellomo G, Comstock JP, Wen D, Hazelwood RL. Proc Soc Exp Biol Med; 1987 Dec; 186(3):348-54. PubMed ID: 3122222 [Abstract] [Full Text] [Related]
5. Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat. McCaleb ML, Sredy J, Millen J, Ackerman DM, Dvornik D. J Diabet Complications; 1988 Dec; 2(1):16-8. PubMed ID: 2968349 [Abstract] [Full Text] [Related]
6. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats. Yue DK, Hanwell MA, Satchell PM, Handelsman DJ, Turtle JR. Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438 [Abstract] [Full Text] [Related]
7. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Mayer JH, Tomlinson DR. Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336 [Abstract] [Full Text] [Related]
8. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats. Cotter MA, Cameron NE, Hohman TC. J Peripher Nerv Syst; 1998 Nov; 3(3):217-23. PubMed ID: 10959252 [Abstract] [Full Text] [Related]
9. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats. Hirata Y, Fujimori S, Okada K. Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821 [Abstract] [Full Text] [Related]
10. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats. Schmidt RE, Plurad SB, Sherman WR, Williamson JR, Tilton RG. Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038 [Abstract] [Full Text] [Related]
11. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration. Williamson JR, Chang K, Tilton RG, Prater C, Jeffrey JR, Weigel C, Sherman WR, Eades DM, Kilo C. Diabetes; 1987 Jul; 36(7):813-21. PubMed ID: 3108058 [Abstract] [Full Text] [Related]
12. The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats. Simard-Duquesne N, Greselin E, Dubuc J, Dvornik D. Metabolism; 1985 Oct; 34(10):885-92. PubMed ID: 3930915 [Abstract] [Full Text] [Related]